Company · CIK 0000878903
Synvista Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001144204-09-010995 · 457.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001144204-09-003890 · 118.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001144204-08-071073 · 100.8 KBSEC(opens sec.gov)
- 10-K/ASynvista Therapeutics, Inc.0001144204-08-024859 · 550.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001144204-08-003601 · 84.5 KBSEC(opens sec.gov)
- 3/ASynvista Therapeutics, Inc.0001209191-08-001108 · 18.4 KBSEC(opens sec.gov)
- SC 13D/ASynvista Therapeutics, Inc.0000950123-08-000052 · 72.4 KBSEC(opens sec.gov)
- 3Synvista Therapeutics, Inc.0001209191-07-056739 · 6.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001144204-07-052087 · 48.1 KBSEC(opens sec.gov)
- 4Insider trades0001209191-07-053793 · 49.7 KBSEC(opens sec.gov)
Insiders
- Atticus Capital LP10% Owner
- BARAKETT TIMOTHY R10% Owner
- Bedard John F.Director
- Berkowitz NoahDirector, President & CEO, 10% Owner
- BRANSOME EDWIN D JRDirector
- BRESLOW MARILYN GDirector
- MCCURDY DAVID KDirector
- Mendel Carl MVP & Chief Medical Officer
- MOCH KENNETH IDirector, CEO, President & Chairman
- MOORE THOMAS ADirector
Tickers
No tickers on record.
Addresses
business
221 WEST GRAND AVENUE
MONTVALE,, NJ, 07645
mailing
221 WEST GRAND AVENUE
MONTVALE,, NJ, 07645
Former names
- ALTEON INC /DE2007-07-31
Same industry